Sharma AD, Büning H, Ott M. Ex Vivo/In vivo Gene Editing in Hepatocytes Using “All-in-One” CRISPR-Adeno-Associated Virus Vectors with a Self-Linearizing Repair Template. iScience. 2020 Jan 24;23(1):100764
nat. Hildegard Büning (Experimental Hematology) Project: Exploring the concept of antigen-decorated Adeno-associated virus (AAV) vector vaccines as therapeutic and-tumor vaccine Laxmi Lokeshwarrao Kata ,
retroviral vectors, derived from gamma-, lenti- and alpharetroviruses (Melanie Galla, Axel Schambach), adeno-associated virus (AAV) (Hildegard Büning) and chromosome-based vectors to support recombinase-mediated
FGF23-Knockoutmäuse und der entsprechenden Überexpression, induziert durch kardialen Gentransfer mittels adeno-assoziierter viraler Vektoren, analysieren wir, inwieweit das kardiale FGF23 per se eine Herzschädigung
Sharma AD , Buning H, Ott M. Ex Vivo/In vivo Gene Editing in Hepatocytes Using "All-in-One" CRISPR-Adeno-Associated Virus Vectors with a Self-Linearizing Repair Template. iScience. 2020;23(1):100764. Song
about the latest advances in heart failure research. For her outstanding presentation on "Engineered adeno-associated viral vectors with an improved in vivo targeting of cardiac fibroblasts" in the keynote [...] studies for Circ-INSR were performed in the context of doxorubicin-induced heart failure. Using adeno-associated viruses (AAVs), the researchers validated that Circ-INSR overexpression exhibits protective
3-022-00488-w. PMID: 36347887 Free PMC article. Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors. Meumann N, Schmithals C, Elenschneider L, Hansen T, Balakrishnan
development' Prof. Dr. Hildegard Büning, Institut für Experimentelle Hämatologie, MHH: 'Tailoring Adeno-Associated Virus (AAV) Vectors for Gene Therapy' Wissenschaftlicher Nachmittag Der wiss. Nachmittag
CT, Delphin M, Lucifora J, Ott M, Hacker UT, Adriouch S, Büning H. Modifying immune responses to adeno-associated virus vectors by capsid engineering . Mol Ther Methods Clin Dev. 2023 Aug 22;30:576-592